Literature DB >> 11044266

Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community.

M Larsson1, G Kronvall, N T Chuc, I Karlsson, F Lager, H D Hanh, G Tomson, T Falkenberg.   

Abstract

OBJECTIVE: To investigate antibiotic use and antibiotic susceptibility of respiratory tract pathogens in children aged 1-5 years in Bavi, Vietnam.
METHOD: Nasopharynx and throat specimens were collected from 200 children from randomly selected households in a demographically defined population. Respiratory isolates were tested for antibiotic susceptibility according to the standard disk diffusion method. A questionnaire survey of carers elicited information on type of antibiotic used, duration of treatment, where the antibiotics had been purchased, type of treatment information retained by carers and episodes of illness preceding the study.
RESULTS: 82% of the children had at least one symptom of acute respiratory tract infection (ARI) in the 4 weeks prior to the study, and of these 91% were treated with antibiotics. The most commonly used antibiotics were ampicillin (74%), penicillin (12%), amoxicillin (11%), erythromycin (5%), tetracycline (4%) and streptomycin (2%). Ampicillin was used for 3.3 days on average (SD:1.8) and penicillin for 2.6 days (SD:0.7). When deciding which antibiotic to use, 67% of the carers consulted the pharmacy seller, 11% decided themselves and 22% followed the doctor's prescription. The carrier rate of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis was 50%, 39% and 17%, respectively. Isolates from 145 children were susceptibility tested, and 74% were found to carry resistant pathogens. Of the tested isolates, 90% of S. pneumoniae, 68% of H. influenzae and 74% of M. catarrhalis were resistant to at least one antibiotic. The mean number of antibiotics (susceptible strains excluded) to which resistance was found was 2.0 (SD:1.2), 2.5 (SD:1.8) and 2.1 (SD:0.9), respectively. S. pneumoniae and H. influenzae showed high resistance to tetracycline (88% and 32%, respectively), trimethoprim/sulphonamide (32% and 44%), and chloramphenicol (25% and 24%). 23% of S. pneumoniae were erythromycin-resistant and 18% of H. influenzae isolates were resistant to ampicillin. There was a significant difference in ampicillin and penicillin resistance between the group of children previously treated with beta lactam antibiotics and the group of children who did not receive antibiotics.
CONCLUSION: As reported by the carers, children in Bavi are treated with antibiotics frequently. Most antibiotics were obtained without consulting a doctor. High levels of antibiotic resistance and high prevalence of multidrug-resistant strains were found among respiratory pathogens. The existence of a large reservoir of resistance genes among children in low-income countries represents a threat to the success of antibiotic therapy throughout the world. Multi-faceted programmes to improve rational use of antibiotics in Vietnam are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044266     DOI: 10.1046/j.1365-3156.2000.00630.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  35 in total

Review 1.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

Review 2.  Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare.

Authors:  Katarina Ilić; Emil Jakovljević; Vesna Skodrić-Trifunović
Journal:  Eur J Pediatr       Date:  2011-10-07       Impact factor: 3.183

3.  Survey of non-prescribed use of antibiotics for children in an urban community in Mongolia.

Authors:  Ganchimeg Togoobaatar; Nayu Ikeda; Moazzam Ali; Munkhbayarlakh Sonomjamts; Sarangerel Dashdemberel; Rintaro Mori; Kenji Shibuya
Journal:  Bull World Health Organ       Date:  2010-09-03       Impact factor: 9.408

4.  Comparative prevalence of antimicrobial resistance in community-acquired urinary tract infection cases from representative States of northern and southern India.

Authors:  Shivani Gupta; Suman Kapur; Dv Padmavathi
Journal:  J Clin Diagn Res       Date:  2014-09-20

5.  Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.

Authors:  Trung Vu Nguyen; Phung Van Le; Chinh Huy Le; Andrej Weintraub
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam.

Authors:  Oliver James Dyar; Nguyen Quynh Hoa; Nguyen V Trung; Ho D Phuc; Mattias Larsson; Nguyen T K Chuc; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2012-04-18       Impact factor: 3.090

7.  Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study.

Authors:  Nguyen Quynh Hoa; Nguyen V Trung; Mattias Larsson; Bo Eriksson; Ho D Phuc; Nguyen Tk Chuc; Cecilia Stalsby Lundborg
Journal:  BMC Infect Dis       Date:  2010-03-31       Impact factor: 3.090

8.  "Practical knowledge" and perceptions of antibiotics and antibiotic resistance among drugsellers in Tanzanian private drugstores.

Authors:  Nina Viberg; Willbrord Kalala; Phare Mujinja; Göran Tomson; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2010-09-16       Impact factor: 3.090

9.  Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.

Authors:  P H Van; P T Binh; N H L Minh; I Morrissey; D Torumkuney
Journal:  J Antimicrob Chemother       Date:  2016-05       Impact factor: 5.790

10.  Reproductive tract infections in women seeking abortion in Vietnam.

Authors:  My Huong Nguyen; Jørgen Kurtzhals; Thi Thu Thuy Do; Vibeke Rasch
Journal:  BMC Womens Health       Date:  2009-01-29       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.